Skip to main content
. 2020 Aug 24;33(2):e1513. doi: 10.1590/0102-672020190001e1513

FIGURE 5. A) Hyperkeratosis (a), hypergranulose (b) and papilla elongation (c); B) mucosal muscle atrophy (a) and exocytosis (b); C) neovascularization and vascular congestion (40x, H&E) .

FIGURE 5